Characterization of the HollandPTC proton therapy beamline dedicated to uveal melanoma treatment and an interinstitutional comparison

PURPOSE: Eye‐dedicated proton therapy (PT) facilities are used to treat malignant intraocular lesions, especially uveal melanoma (UM). The first commercial ocular PT beamline from Varian was installed in the Netherlands. In this work, the conceptual design of the new eyeline is presented. In additio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleury, Emmanuelle, Trnková, Petra, Spruijt, Kees, Herault, Joël, Lebbink, Franciska, Heufelder, Jens, Hrbacek, Jan, Horwacik, Tomasz, Kajdrowicz, Tomasz, Denker, Andrea, Gerard, Anaïs, Hofverberg, Petter, Mamalui, Maria, Slopsema, Roelf, Pignol, Jean‐Philippe, Hoogeman, Mischa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
EMERGING IMAGING AND THERAPY MODALITIES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457201/
https://www.ncbi.nlm.nih.gov/pubmed/34091930
http://dx.doi.org/10.1002/mp.15024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457201/
https://www.ncbi.nlm.nih.gov/pubmed/34091930
http://dx.doi.org/10.1002/mp.15024

Ejemplares similares